abstract |
The present invention provides a method of using a compound of formula (1) as an agonist of GPR139 to treat a disease, disorder or condition associated with GPR139, certain compounds covered by formula (1), pharmaceutical compositions thereof, for Processes for the preparation of the compounds and their intermediates. |